Drugmakers Fight Multifront Legal Battles Over GLP-1s
By Hannah Albarazi · January 6, 2026, 5:58 PM EST
In the years since the U.S. Food and Drug Administration approved GLP-1 drugs for Type 2 diabetes and, later, for weight loss, demand has surged, generating estimated revenues of more than...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login